229 related articles for article (PubMed ID: 26889844)
21. Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia.
Kalisch Ellett LM; Pratt NL; Ramsay EN; Barratt JD; Roughead EE
J Am Geriatr Soc; 2014 Oct; 62(10):1916-22. PubMed ID: 25284144
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of anticholinergic burden of medications in older adults.
West T; Pruchnicki MC; Porter K; Emptage R
J Am Pharm Assoc (2003); 2013; 53(5):496-504. PubMed ID: 24030127
[TBL] [Abstract][Full Text] [Related]
23. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.
Rozenbaum MH; Mangen MJ; Huijts SM; van der Werf TS; Postma MJ
Vaccine; 2015 Jun; 33(28):3193-9. PubMed ID: 25981488
[TBL] [Abstract][Full Text] [Related]
24. Use of Medications with Anticholinergic Activity and Self-Reported Injurious Falls in Older Community-Dwelling Adults.
Richardson K; Bennett K; Maidment ID; Fox C; Smithard D; Kenny RA
J Am Geriatr Soc; 2015 Aug; 63(8):1561-9. PubMed ID: 26200894
[TBL] [Abstract][Full Text] [Related]
25. Association between anticholinergic medication uses and the risk of pneumonia in elderly adults: a meta-analysis and systematic review.
Wu M; Li Z; Zheng W; Zhuang J; Wu S; Zhou Q; Cai J; Zheng H; Zeng G; Zhang W; Zhang S; Lin M; Zhong X; Zhang Q
Ann Med; 2023 Dec; 55(1):2209736. PubMed ID: 37190776
[TBL] [Abstract][Full Text] [Related]
26. Association of anticholinergic drug exposure with the risk of dementia among older adults in Japan: The LIFE Study.
Okita Y; Kitamura T; Komukai S; Zha L; Komatsu M; Narii N; Murata F; Megumi M; Gon Y; Kimura Y; Kiyohara K; Sobue T; Fukuda H
Int J Geriatr Psychiatry; 2023 Dec; 38(12):e6029. PubMed ID: 38041399
[TBL] [Abstract][Full Text] [Related]
27. Inhaled drugs as risk factors for community-acquired pneumonia.
Almirall J; Bolíbar I; Serra-Prat M; Palomera E; Roig J; Hospital I; Carandell E; Agustí M; Ayuso P; Estela A; Torres A;
Eur Respir J; 2010 Nov; 36(5):1080-7. PubMed ID: 20525710
[TBL] [Abstract][Full Text] [Related]
28. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality.
Corrales-Medina VF; Musher DM; Wells GA; Chirinos JA; Chen L; Fine MJ
Circulation; 2012 Feb; 125(6):773-81. PubMed ID: 22219349
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia.
Bhattacharya R; Chatterjee S; Carnahan RM; Aparasu RR
Am J Geriatr Pharmacother; 2011 Dec; 9(6):434-41. PubMed ID: 22030114
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for community-acquired pneumonia in German adults: the impact of children in the household.
Schnoor M; Klante T; Beckmann M; Robra BP; Welte T; Raspe H; Schäfer T;
Epidemiol Infect; 2007 Nov; 135(8):1389-97. PubMed ID: 17291378
[TBL] [Abstract][Full Text] [Related]
31. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV
Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573
[TBL] [Abstract][Full Text] [Related]
32. Long-term exposure to ambient air pollution and risk of hospitalization with community-acquired pneumonia in older adults.
Neupane B; Jerrett M; Burnett RT; Marrie T; Arain A; Loeb M
Am J Respir Crit Care Med; 2010 Jan; 181(1):47-53. PubMed ID: 19797763
[TBL] [Abstract][Full Text] [Related]
33. Changes in the Use of Long-Term Medications Following Incident Dementia Diagnosis.
Anderson TS; Ayanian JZ; Curto VE; Politzer E; Souza J; Zaslavsky AM; Landon BE
JAMA Intern Med; 2023 Oct; 183(10):1098-1108. PubMed ID: 37603340
[TBL] [Abstract][Full Text] [Related]
34. The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort.
Obiora E; Hubbard R; Sanders RD; Myles PR
Thorax; 2013 Feb; 68(2):163-70. PubMed ID: 23220867
[TBL] [Abstract][Full Text] [Related]
35. Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study.
Gorricho J; Garjón J; Alonso A; Celaya MC; Saiz LC; Erviti J; López A
Br J Clin Pharmacol; 2017 Sep; 83(9):2034-2044. PubMed ID: 28294379
[TBL] [Abstract][Full Text] [Related]
36. Determinants of community-acquired pneumonia in children and young adults in primary care.
Teepe J; Grigoryan L; Verheij TJ
Eur Respir J; 2010 May; 35(5):1113-7. PubMed ID: 20436174
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Anticholinergic Medication Use in the Program of All-Inclusive Care for the Elderly.
Covington LP; McCarrell J; Hoerster NS
Consult Pharm; 2016 Mar; 31(3):168-74. PubMed ID: 26975596
[TBL] [Abstract][Full Text] [Related]
38. The use of anticholinergic medication is associated with an increased risk of stroke-associated pneumonia.
Gradek-Kwinta E; Slowik A; Dziedzic T
Aging Clin Exp Res; 2022 Aug; 34(8):1935-1938. PubMed ID: 35416612
[TBL] [Abstract][Full Text] [Related]
39. Environmental risk factors for community-acquired pneumonia hospitalization in older adults.
Loeb M; Neupane B; Walter SD; Hanning R; Carusone SC; Lewis D; Krueger P; Simor AE; Nicolle L; Marrie TJ
J Am Geriatr Soc; 2009 Jun; 57(6):1036-40. PubMed ID: 19467147
[TBL] [Abstract][Full Text] [Related]
40. [Case-control study of risk factors for community acquired pneumonia among old persons in Shanghai City].
Bai Q; Xu B; Sun T; Zhang T
Wei Sheng Yan Jiu; 2007 Sep; 36(5):587-90. PubMed ID: 18095574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
